RxDoctor Payments Data

Debra Prow

Hematology & Oncology · Gilbert, IANPI 1992736771

Payments from drug & device makers

What this record shows

This record is dominated by education: $11 of the $11 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Merck. That places this record below the midpoint for hematology & oncology clinicians in IA, where the typical reported total is $603.

$11in general payments, 2019–2025

Across 1 payment — averaging $10.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$11
$400,189in research payments, 2019–2025

Across 214 payments — averaging $1870.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$261K
  • Helsinn Healthcare SA$43K
  • Amgen$26K
  • Bristol Myers Squibb$23K
  • Incyte Corporation$10K
  • Morphosys AG$9K
  • plus $28K from 5 others

What the payments were for

  • Education$11100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck1$11

How this compares

$11 in reported general payments places this provider in the 5th percentile of 75 hematology & oncology providers in Iowa.

See all hematology & oncology providers in Iowa

Most prescribed under Part D

DrugClaimsCost to plans & patients
Potassium Chloride13$344
Ropinirole Hcl12$280
Donepezil Hcl12$252
Memantine Hcl12$252
Anastrozole11$159

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Gilbert

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →